TNBC, which lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and HER2, accounts for only 20% of all breast cancers, yet is responsible for a relatively large proportion of breast cancer deaths. Here, ERBB2 is linked to breast cancer.